Luminex Corporation (NASDAQ: LMNX) and Varian Medical Systems (NYSE:VAR) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, earnings, valuation, institutional ownership, risk, analyst recommendations and profitability.
This is a breakdown of recent ratings for Luminex Corporation and Varian Medical Systems, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Varian Medical Systems||2||6||2||0||2.00|
Luminex Corporation presently has a consensus price target of $19.33, suggesting a potential downside of 7.01%. Varian Medical Systems has a consensus price target of $94.94, suggesting a potential downside of 7.17%. Given Luminex Corporation’s higher probable upside, equities analysts clearly believe Luminex Corporation is more favorable than Varian Medical Systems.
Luminex Corporation pays an annual dividend of $0.24 per share and has a dividend yield of 1.2%. Varian Medical Systems does not pay a dividend. Luminex Corporation pays out 75.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.
Institutional & Insider Ownership
78.0% of Luminex Corporation shares are held by institutional investors. Comparatively, 99.3% of Varian Medical Systems shares are held by institutional investors. 6.9% of Luminex Corporation shares are held by insiders. Comparatively, 0.9% of Varian Medical Systems shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
This table compares Luminex Corporation and Varian Medical Systems’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Varian Medical Systems||9.50%||24.70%||11.12%|
Valuation & Earnings
This table compares Luminex Corporation and Varian Medical Systems’ gross revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||EBITDA||Earnings Per Share||Price/Earnings Ratio|
|Luminex Corporation||$297.73 million||3.08||$49.82 million||$0.32||64.97|
|Varian Medical Systems||$3.27 billion||2.87||$643.00 million||$3.04||33.64|
Varian Medical Systems has higher revenue and earnings than Luminex Corporation. Varian Medical Systems is trading at a lower price-to-earnings ratio than Luminex Corporation, indicating that it is currently the more affordable of the two stocks.
Volatility & Risk
Luminex Corporation has a beta of 0.29, suggesting that its share price is 71% less volatile than the S&P 500. Comparatively, Varian Medical Systems has a beta of 0.56, suggesting that its share price is 44% less volatile than the S&P 500.
Varian Medical Systems beats Luminex Corporation on 11 of the 16 factors compared between the two stocks.
Luminex Corporation Company Profile
Luminex Corporation develops, manufactures and sells biological testing technologies with applications throughout the diagnostics, pharmaceutical and life sciences industries. The Company’s products are focused on the molecular diagnostic testing market, which includes human genetics, personalized medicine and infectious disease segments. The Company has a range of instruments using its xMAP technology, which includes its LUMINEX 100/200 systems offer 100-plex testing; the Company’s FLEXMAP 3D system is its high-throughput, 500-plex testing system, and its MAGPIX system provides 50-plex testing using imaging rather than flow cytometry. By using its xMAP technology, the end users are able to generate multiple simultaneous results per sample. The Company primarily serves the diagnostics, pharmaceutical and life sciences industries by marketing products, including its testing equipment and assays, to a range of testing laboratories.
Varian Medical Systems Company Profile
Varian Medical Systems, Inc. is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. The Company also has Varian Particle Therapy (VPT) and the operations of the Ginzton Technology Center (GTC). Its VPT business develops, designs, manufactures, sells and services products and systems for delivering proton therapy, another form of external beam radiotherapy using proton beams for the treatment of cancer. Its ProBeam system is capable of delivering intensity modulated proton therapy (IMPT) using pencil beam scanning technology. Its ProBeam Compact is a single room proton therapy product.
Receive News & Ratings for Luminex Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Luminex Corporation and related companies with MarketBeat.com's FREE daily email newsletter.